Literature DB >> 2837654

Ligand-induced tyrosine kinase activity of the colony-stimulating factor 1 receptor in a murine macrophage cell line.

J R Downing1, C W Rettenmier, C J Sherr.   

Abstract

Metabolic labeling of simian virus 40-immortalized murine macrophages with 32Pi and immunoblotting with antibodies to phosphotyrosine demonstrated that the c-fms proto-oncogene product (colony-stimulating factor 1 [CSF-1] receptor) was phosphorylated on tyrosine in vivo and rapidly degraded in response to CSF-1. Stimulation of the CSF-1 receptor also induced immediate phosphorylation of several other cellular proteins on tyrosine. By contrast, the mature cell surface glycoprotein encoded by the v-fms oncogene was phosphorylated on tyrosine in the absence of CSF-1, suggesting that it functions as a ligand-independent kinase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837654      PMCID: PMC363340          DOI: 10.1128/mcb.8.4.1795-1799.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

2.  Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages.

Authors:  R Bravo; M Neuberg; J Burckhardt; J Almendral; R Wallich; R Müller
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

3.  Tyrosine phosphorylations in vivo associated with v-fms transformation.

Authors:  D K Morrison; P J Browning; M F White; T M Roberts
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

4.  Synthesis, post-translational processing, and autocrine transforming activity of a carboxylterminal truncated form of colony stimulating factor-1.

Authors:  J M Heard; M F Roussel; C W Rettenmier; C J Sherr
Journal:  Oncogene Res       Date:  1987 Sep-Oct

5.  Phosphotyrosine-containing proteins isolated by affinity chromatography with antibodies to a synthetic hapten.

Authors:  A H Ross; D Baltimore; H N Eisen
Journal:  Nature       Date:  1981-12-17       Impact factor: 49.962

6.  Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5.

Authors:  C Morgan; J W Pollard; E R Stanley
Journal:  J Cell Physiol       Date:  1987-03       Impact factor: 6.384

7.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).

Authors:  M F Roussel; T J Dull; C W Rettenmier; P Ralph; A Ullrich; C J Sherr
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

8.  Purification of the colony-stimulating factor 1 receptor and demonstration of its tyrosine kinase activity.

Authors:  Y G Yeung; P T Jubinsky; A Sengupta; D C Yeung; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

9.  Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage.

Authors:  J Woolford; V Rothwell; L Rohrschneider
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

10.  gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine.

Authors:  T Tamura; E Simon; H Niemann; G T Snoek; H Bauer
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

View more
  40 in total

1.  Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1.

Authors:  H Hirai; C J Sherr
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

2.  Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.

Authors:  T J Velu; W C Vass; D R Lowy; L Beguinot
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

3.  Identification and subcellular localization of proteins that are rapidly phosphorylated in tyrosine in response to colony-stimulating factor 1.

Authors:  A Sengupta; W K Liu; Y G Yeung; D C Yeung; A R Frackelton; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth.

Authors:  J R Haynes; J R Downing
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

5.  A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase.

Authors:  J A Diehl; C J Sherr
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures.

Authors:  G V Borzillo; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

7.  Phosphatidylcholine hydrolysis and c-myc expression are in collaborating mitogenic pathways activated by colony-stimulating factor 1.

Authors:  X X Xu; T G Tessner; C O Rock; S Jackowski
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

8.  Tyrosine 706 and 807 phosphorylation site mutants in the murine colony-stimulating factor-1 receptor are unaffected in their ability to bind or phosphorylate phosphatidylinositol-3 kinase but show differential defects in their ability to induce early response gene transcription.

Authors:  P van der Geer; T Hunter
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.

Authors:  J Y Kato; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid-G1 stage of the cell cycle and overrides constitutive c-myc expression.

Authors:  C O Rock; J L Cleveland; S Jackowski
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.